IOVANCE BIOTHERAPEUTICS INC's ticker is IOVA and the CUSIP is 462260100. A total of 239 filers reported holding IOVANCE BIOTHERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.52 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $170,000 | -25.1% | 10,196 | -14.1% | 0.00% | -25.0% |
| Q4 2021 | $227,000 | -40.4% | 11,867 | -23.2% | 0.00% | -42.9% |
| Q3 2021 | $381,000 | -4.5% | 15,454 | +0.7% | 0.01% | 0.0% |
| Q2 2021 | $399,000 | -24.4% | 15,339 | -8.1% | 0.01% | -36.4% |
| Q1 2021 | $528,000 | -40.3% | 16,687 | -12.5% | 0.01% | -42.1% |
| Q4 2020 | $885,000 | +13.0% | 19,076 | -19.7% | 0.02% | -5.0% |
| Q3 2020 | $783,000 | +42.6% | 23,766 | +18.7% | 0.02% | +42.9% |
| Q2 2020 | $549,000 | – | 20,022 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ACUTA CAPITAL PARTNERS, LLC | 2,944,201 | $27,999,000 | 13.31% |
| Broadfin Capital, LLC | 4,328,303 | $41,162,000 | 8.50% |
| GREAT POINT PARTNERS LLC | 5,567,348 | $52,945,000 | 5.24% |
| FRAZIER MANAGEMENT LLC | 2,188,331 | $20,811,000 | 5.01% |
| Avoro Capital Advisors LLC | 10,530,862 | $100,148,000 | 4.33% |
| Prosight Management, LP | 917,080 | $8,721,000 | 3.82% |
| Perceptive Advisors | 12,235,811 | $116,362,000 | 3.28% |
| Ghost Tree Capital, LLC | 1,150,000 | $10,937,000 | 2.86% |
| QVT Financial LP | 1,021,361 | $9,241,000 | 2.32% |
| Cheyne Capital Management (UK) LLP | 186,500 | $1,774,000 | 1.66% |